In a tumor tissue microarray (TMA) analysis of 312 samples from 153 human patients, we found that HK2 upregulation occurs at the onset of cirrhosis, increases in dysplasia, and is expressed to the greatest extent in carcinoma, suggesting that the level of HK2 correlates with hepatic disease progression regardless of cause8. Here, HK2 is linked to neoplasm.